Detalhe da pesquisa
1.
Hepatitis C virus infection increases autophagosome stability by suppressing lysosomal fusion through an Arl8b-dependent mechanism.
J Biol Chem
; 294(39): 14257-14266, 2019 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31383738
2.
Fast hepatitis C virus RNA elimination and NS5A redistribution by NS5A inhibitors studied by a multiplex assay approach.
Antimicrob Agents Chemother
; 59(6): 3482-92, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845863
3.
Hepatitis C and alcohol exacerbate liver injury by suppression of FOXO3.
Am J Pathol
; 183(6): 1803-1814, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24225087
4.
Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein.
Antimicrob Agents Chemother
; 57(7): 3250-61, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23629699
5.
From features to categories: The development of inductive generalization.
J Exp Psychol Learn Mem Cogn
; 49(10): 1615-1634, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307326
6.
Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus.
Viruses
; 15(4)2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37112961
7.
The conundrum of relapse in STAT-C therapy: does HCV play the Red Queen or Rip Van Winkle?
Semin Liver Dis
; 31(4): 410-9, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22189980
8.
Identification of HCV protease inhibitor resistance mutations by selection pressure-based method.
Nucleic Acids Res
; 37(10): e74, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19395595
9.
Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc.
J Virol
; 83(23): 12151-63, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19776131
10.
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.
Hepatology
; 50(6): 1709-18, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19787809
11.
Selection and characterization of hepatitis C virus replicons dually resistant to the polymerase and protease inhibitors HCV-796 and boceprevir (SCH 503034).
Antimicrob Agents Chemother
; 53(2): 401-11, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18936191
12.
Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport.
J Virol
; 82(13): 6492-500, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18448546
13.
Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus.
Viruses
; 11(11)2019 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31717338
14.
Characterization of resistance mutations against HCV ketoamide protease inhibitors.
Antiviral Res
; 77(3): 177-85, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18201776
15.
Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.
Gastroenterology
; 140(3): 755-60, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21255574
16.
Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy.
Cancer Res
; 63(14): 4003-8, 2003 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12873998
17.
Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model.
Clin Cancer Res
; 10(21): 7199-206, 2004 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15534093
18.
Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
Laryngoscope
; 115(3): 391-404, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15744147
19.
Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies.
Virology
; 444(1-2): 329-36, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23876458
20.
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial.
Antivir Ther
; 18(3): 387-97, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406826